Tag Nanobodies

Health

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

In a recent study published in Frontiers in Immunology, a team of researchers from the United States developed an affordable, non-invasive, inhalable prophylactic treatment consisting of immunoglobulin (Ig) A fused nanobodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron…

GT
December 2, 2022

Health

Chitin-immobilized nanobodies for SARS-CoV-2 detection

In a recent study posted to bioRxiv*, researchers demonstrated a novel strategy to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using chitin-immobilized nanobodies. Study: Efficient SARS-CoV-2 detection utilizing chitin-immobilized nanobodies synthesized in Ustilago maydis. Image Credit: CROCOTHERY/Shutterstock Background Shark…

GT
November 21, 2022

Health

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

In a recent study published in iScience, researchers engineered biparatopic nanobodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Study: Biparatopic nanobodies targeting the receptor binding domain efficiently neutralise SARS-CoV-2. Image Credit: Juan Gaertner/Shutterstock Background Despite the rapid development of…

GT
October 5, 2022

Health

Plant production of nanobodies that neutralize the interaction between ACE2 receptor and SARS-CoV-2 spike protein

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated the production of nanobodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. Study: Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with…

GT
September 7, 2022

Health

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

The coronavirus disease 2019 (COVID-19) pandemic, caused by the rapid outbreak of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), has drastically affected the healthcare system and economy worldwide. Several COVID-19 vaccines have received emergency use authorization (EUA) from global regulatory bodies,…

GT
September 2, 2022

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Chitin-immobilized nanobodies for SARS-CoV-2 detection

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Plant production of nanobodies that neutralize the interaction between ACE2 receptor and SARS-CoV-2 spike protein

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

Trending now